
Navonil DS
@navonilde
(Pronouns He/Him). DAD/Husband/Scientist @ProstateCancer @CancerGenomics @Biomarker_Research @Mountain_Lover @DNA repair @Signature 'tweet are mine'
ID: 38403934
07-05-2009 09:57:19
689 Tweet
358 Followers
684 Following

Fabio Schutz Toni Choueiri, MD Tom Powles Laurence Albiges Guillermo de Velasco Sumanta K. Pal, MD, FASCO Neeraj Agarwal, MD, FASCO You can read more in the paper published today in Cancer Discovery concurrently with the presentation: doi.org/10.1158/2159-8…


Cancer care should be as unique as the patients we serve. Razelle Kurzrock, MD is leading the charge in precision medicine, ensuring patients get treatments tailored to their tumor profiles. mcw-cancercenter.cmail19.com/t/r-e-thjdlyik… #WomensHistoryMonth #WomenInScience #PrecisionMedicine


Closing an incredible era leading American Cancer Society + American Cancer Society Cancer Action Network. So proud of what we accomplished in the last 4 yrs and could not ask for a better team. TY Team ACS for this farewell video—I will treasure it! 💙

NIH is centralizing peer review of all applications for grants, cooperative agreements and research and development contracts within the agency’s Previously the NIH Center for Scientific Review. This is expected to save NIH more than $65 million annually & make the review process more efficient.




Exciting 177Lu-PSMA-617 has been approved by the FDA for use prior to chemotherapy based on the PSMAfore results. Perfect timing, during day 1 of the PSMA and Beyond Conference! bit.ly/42lfdlz

I loved this essay on scientific writing in Nature Biotechnology (rdcu.be/edUCp). It highlights a key lesson I’ve applied throughout my career: the power of reading, thinking, and keeping a notebook with your ideas. Let me explain why this matters… 🧵👇


ANNOUNCEMENT: RFA for 2025 Prostate Cancer Foundation TACTICAL Award Letters Of Intent, for multi-institutional research projects to target lethal #ProstateCancer, in 6 specified topic areas. LOI DEADLINE: May 19, 2025 View RFA: res.cloudinary.com/pcf/images/v17… View LOI form: res.cloudinary.com/pcf/images/v17…


At PCF, we advocate for early and regular prostate cancer screenings. In the wake of former President Biden’s diagnosis, Phillip Koo, MD spoke with the The Washington Post about this philosophy and why we believe that early screening and detection is critical. bit.ly/3H1RoqZ


As of January 2022, an estimated 18.1M people in the U.S. are cancer survivors. That number is expected to grow to 22.2M by 2030. At Medical College of Wisconsin Cancer Center, our researchers & clinicians are working to accelerate that progress. cancer.mcw.edu/researchers-an…



Milwaukee brewers just won with Home Run #PCFhomeRun PCF Science Prostate Cancer Foundation


Thank you PCF and Milwaukee Brewers . #PCFHomeRunChallenge..Can't be happier as Milwaukee Brewers scored the Home Run.


In high-risk prostate cancer, radiotherapy plus ADT significantly reduces the risk of distant metastasis compared to surgery-based approaches. However, post-metastasis survival does not differ between treatments. European Urology Oncology Daniel E Spratt OncoAlert Advanced Prostate Cancer Consensus Conference European Association of Urology (EAU)

